Rituximab in B-Lineage Adult Acute Lymphoblastic LeukemiaSébastien Maury, Hervé Dombret, Nicolas Boissel et al.|New England Journal of Medicine|2016Cited by 347
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trialStéphane de Botton, for the European Apl Group, Sylvie Chevret et al.|British Journal of Haematology|2000Cited by 145
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trialStéphane de Botton, for the European Apl Group, Sylvie Chevret et al.|British Journal of Haematology|2000Cited by 79
Addition of Rituximab Improves the Outcome of Adult Patients with CD20-Positive, Ph-Negative, B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Graall-R 2005 StudySébastien Maury, Hervé Dombret, Sylvie Chevret et al.|Blood|2015Cited by 44